Coliprotec F4/F18 1X200Dose Aa

Target species Pigs. Indications for use, specifying the target species For active immunisation of pigs from 18 days of age against enterotoxigenic F4-positive and F18-positive Escherichia coli in order to: - reduce the incidence of moderate to severe post-weaning E. coli diarrhoea (PWD) in infected pigs; - reduce the faecal shedding of enterotoxigenic F4-positive and F18-positive E. coli from infected pigs. Onset of immunity: 7 days after vaccination Duration of immunity: 21 days after vaccination Contraindications None. Special warnings for each target species It is not recommended to vaccinate animals undergoing immunosuppressive treatment or to vaccinate animals undergoing antibacterial treatment effective against E. coli. Special precautions for use Special precautions for use in animals. Vaccinate healthy animals only. The vaccine strains may be excreted by vaccinated piglets for at least 14 days following vaccination. The vaccine strains readily spread to other pigs in contact to vaccinated pigs. Unvaccinated pigs in contact with vaccinated pigs will harbour and shed the vaccine strains similarly to vaccinated pigs. During this time, the contact of immunosuppressed pigs with vaccinated pigs should be avoided. Special precautions to be taken by the person administering the veterinary medicinal product to animals. Personal protective equipment consisting of protective disposable gloves and safety glasses should be worn when handling the veterinary medicinal product. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician. In case of spillage onto skin, rinse with water and seek medical advice immediately and show the package leaflet or the label to the physician. Adverse reactions (frequency and seriousness) No adverse reactions have been observed. Use during pregnancy, lactation or lay The use is not recommended during pregnancy. Interaction with other medicinal products and other forms of interaction No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.